The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

1. Clemente-Bautista, S.
2. Trocóniz, I.F.
3. Segarra-Cantón, Ó.
4. Salvador-Marín, S.
5. Parramón-Teixidó, C.J.
6. Álvarez-Beltrán, M.
7. López-Fernández, L.A.
8. Colom, H.
9. Cabañas-Poy, M.J.
10. Gorgas-Torner, M.Q.
11. Miarons, M.